Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-World Setting. Diabetes Care 2024;47:216-224

Diabetes Care. 2024 May 1;47(5):e44-e45. doi: 10.2337/dc24-0055.

Authors

Maha Lebbar¹, Zoé Henry², Charles Thivolet¹

Affiliations

¹ Center for Diabetes, DIAB-eCARE, Hospices Civils de Lyon, Lyon, France.
² Federation of Endocrinology, Diabetes and Nutrition, Hospices Civils de Lyon, Lyon, France.

PMID: 38640407
DOI: 10.2337/dc24-0055

No abstract available

MeSH terms

Blood Glucose*
Diabetes Mellitus, Type 1*
Humans
Hypoglycemic Agents
Patient Reported Outcome Measures

Substances

Blood Glucose
Hypoglycemic Agents